These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 17609431)
1. Intensive chemotherapy regimen (LMB86) for St Jude stage IV AIDS-related Burkitt lymphoma/leukemia: a prospective study. Galicier L; Fieschi C; Borie R; Meignin V; Daniel MT; Gérard L; Oksenhendler E Blood; 2007 Oct; 110(8):2846-54. PubMed ID: 17609431 [TBL] [Abstract][Full Text] [Related]
2. Clinical outcomes of AIDS-related Burkitt lymphoma: a multi-institution retrospective survey in Japan. Kojima Y; Hagiwara S; Uehira T; Ajisawa A; Kitanaka A; Tanuma J; Okada S; Nagai H Jpn J Clin Oncol; 2014 Apr; 44(4):318-23. PubMed ID: 24558129 [TBL] [Abstract][Full Text] [Related]
3. Intensive chemotherapy with cyclophosphamide, doxorubicin, high-dose methotrexate/ifosfamide, etoposide, and high-dose cytarabine (CODOX-M/IVAC) for human immunodeficiency virus-associated Burkitt lymphoma. Wang ES; Straus DJ; Teruya-Feldstein J; Qin J; Portlock C; Moskowitz C; Goy A; Hedrick E; Zelenetz AD; Noy A Cancer; 2003 Sep; 98(6):1196-205. PubMed ID: 12973843 [TBL] [Abstract][Full Text] [Related]
4. Hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone and highly active antiretroviral therapy for patients with acquired immunodeficiency syndrome-related Burkitt lymphoma/leukemia. Cortes J; Thomas D; Rios A; Koller C; O'Brien S; Jeha S; Faderl S; Kantarjian H Cancer; 2002 Mar; 94(5):1492-9. PubMed ID: 11920506 [TBL] [Abstract][Full Text] [Related]
5. Treatment outcome of adult patients with Burkitt lymphoma: results using the LMB protocol in Korea. Choi MK; Jun HJ; Lee SY; Kim KH; Lim DH; Kim K; Ko YH; Kim WS; Kim SJ Ann Hematol; 2009 Nov; 88(11):1099-106. PubMed ID: 19288103 [TBL] [Abstract][Full Text] [Related]
6. AIDS-related Burkitt's lymphoma versus diffuse large-cell lymphoma in the pre-highly active antiretroviral therapy (HAART) and HAART eras: significant differences in survival with standard chemotherapy. Lim ST; Karim R; Nathwani BN; Tulpule A; Espina B; Levine AM J Clin Oncol; 2005 Jul; 23(19):4430-8. PubMed ID: 15883411 [TBL] [Abstract][Full Text] [Related]
7. Highly effective treatment of acquired immunodeficiency syndrome-related lymphoma with dose-adjusted EPOCH: impact of antiretroviral therapy suspension and tumor biology. Little RF; Pittaluga S; Grant N; Steinberg SM; Kavlick MF; Mitsuya H; Franchini G; Gutierrez M; Raffeld M; Jaffe ES; Shearer G; Yarchoan R; Wilson WH Blood; 2003 Jun; 101(12):4653-9. PubMed ID: 12609827 [TBL] [Abstract][Full Text] [Related]
8. Intensive, very short-term chemotherapy for advanced Burkitt's lymphoma in children. Spreafico F; Massimino M; Luksch R; Casanova M; Cefalo GS; Collini P; Ferrari A; Polastri D; Terenziani M; Gasparini M; Fossati-Bellani F J Clin Oncol; 2002 Jun; 20(12):2783-8. PubMed ID: 12065554 [TBL] [Abstract][Full Text] [Related]
9. Excellent immunological recovery following CODOX-M/IVAC, an effective intensive chemotherapy for HIV-associated Burkitt's lymphoma. Montoto S; Wilson J; Shaw K; Heath M; Wilson A; McNamara C; Orkin C; Nelson M; Johnson M; Bower M; Cwynarski K AIDS; 2010 Mar; 24(6):851-6. PubMed ID: 20124971 [TBL] [Abstract][Full Text] [Related]
11. Intensive chemotherapy (LNHIV-91 regimen) and G-CSF for HIV associated non-Hodgkin's lymphoma. Oksenhendler E; Gerard L; Dubreuil ML; Levy Y; Matheron S; Cazals-Hatem D; Chevret S; Clauvel JP Leuk Lymphoma; 2000 Sep; 39(1-2):87-95. PubMed ID: 10975387 [TBL] [Abstract][Full Text] [Related]
12. Rituximab with chemotherapy in children and adolescents with central nervous system and/or bone marrow-positive Burkitt lymphoma/leukaemia: a Children's Oncology Group Report. Goldman S; Smith L; Galardy P; Perkins SL; Frazer JK; Sanger W; Anderson JR; Gross TG; Weinstein H; Harrison L; Shiramizu B; Barth M; Cairo MS Br J Haematol; 2014 Nov; 167(3):394-401. PubMed ID: 25066629 [TBL] [Abstract][Full Text] [Related]
13. [Successful treatment with hyper-CVAD and highly active anti-retroviral therapy (HAART) for AIDS-related Burkitt lymphoma]. Suzuki K; Nakazato T; Sanada Y; Mihara A; Tachikawa N; Kurai H; Yoshimura Y; Hayashi H; Yoshida S; Kakimoto T Rinsho Ketsueki; 2010 Mar; 51(3):207-12. PubMed ID: 20379116 [TBL] [Abstract][Full Text] [Related]
14. Modified cyclophosphamide, vincristine, doxorubicin, and methotrexate (CODOX-M)/ifosfamide, etoposide, and cytarabine (IVAC) therapy with or without rituximab in Japanese adult patients with Burkitt lymphoma (BL) and B cell lymphoma, unclassifiable, with features intermediate between diffuse large B cell lymphoma and BL. Maruyama D; Watanabe T; Maeshima AM; Nomoto J; Taniguchi H; Azuma T; Mori M; Munakata W; Kim SW; Kobayashi Y; Matsuno Y; Tobinai K Int J Hematol; 2010 Dec; 92(5):732-43. PubMed ID: 21120644 [TBL] [Abstract][Full Text] [Related]
15. AIDS-associated Burkitt or Burkitt-like lymphoma: short intensive polychemotherapy is feasible and effective. Hoffmann C; Wolf E; Wyen C; Fätkenheuer G; Van Lunzen J; Stellbrink HJ; Stoehr A; Plettenberg A; Jaeger H; Noppeney R; Hentrich M; Goekbuget N; Hoelzer D; Horst HA Leuk Lymphoma; 2006 Sep; 47(9):1872-80. PubMed ID: 17065000 [TBL] [Abstract][Full Text] [Related]
16. Short-term weekly chemotherapy followed by high-dose therapy with autologous bone marrow transplantation for lymphoblastic and Burkitt's lymphomas in adult patients. Jost LM; Jacky E; Dommann-Scherrer C; Honegger HP; Maurer R; Sauter C; Stahel RA Ann Oncol; 1995 May; 6(5):445-51. PubMed ID: 7545428 [TBL] [Abstract][Full Text] [Related]
17. A multicenter phase II study incorporating high-dose rituximab and liposomal doxorubicin into the CODOX-M/IVAC regimen for untreated Burkitt's lymphoma. Evens AM; Carson KR; Kolesar J; Nabhan C; Helenowski I; Islam N; Jovanovic B; Barr PM; Caimi PF; Gregory SA; Gordon LI Ann Oncol; 2013 Dec; 24(12):3076-81. PubMed ID: 24146219 [TBL] [Abstract][Full Text] [Related]